Skip to content

RxSight, Inc. RXST Current maturities of long-term debt

Current maturities of long-term debt at other companies

Precision Optics Corporation logo
Precision Optics CorporationPOCI

Other financials

Income statement

See full
Revenue$30.9M-18.5%
Gross profit$23.5M-17.1%
Operating income-$17.8M-67.0%
Net income-$15.9M-93.9%
EPS (diluted)-$0.38-90.0%

Balance sheet

See full
Cash & equivalents$17.6M-37.2%
Total debt$10.8M-10.1%
Total equity$267.3M-4.3%
Total assets$304.0M-2.9%

Cash flow

See full
Operating cash flow-$10.9M-23.3%
CapEx$759.0K+32.0%
Free cash flow-$11.7M-23.8%

Valuation

See full
Market cap$232.23M-56.8%
Enterprise value$225.49M-55.7%
P/S1.8×-1.8×

Profitability

See full
Gross margin77%+5.1pp
Operating margin-43.4%+128pp
Net margin-36.6%-867pp
FCF margin-16.9%+4.9pp

Returns & leverage

See full
Return on equity-17.1%+12.6pp
Debt / equity0.0×
Current ratio10.2×-2.5×

Where this comes from

Reported directly by RxSight, Inc. in its filing.

Tagged under the XBRL concept us-gaap:FinanceLeaseLiabilityCurrent.

The official record: RxSight, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about RxSight, Inc.'s current maturities of long-term debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is RxSight, Inc.'s current maturities of long-term debt?
RxSight, Inc. (RXST) reported current maturities of long-term debt of $30K in Q1 2026.
How has RxSight, Inc.'s current maturities of long-term debt changed year-over-year?
RxSight, Inc.'s current maturities of long-term debt decreased by 6.3% year-over-year, from $32K to $30K.
What is the long-term trend for RxSight, Inc.'s current maturities of long-term debt?
Over 5 years (2020 to 2025), RxSight, Inc.'s current maturities of long-term debt has grown at a 0.7% compound annual growth rate (CAGR), from $27K to $28K.